title: Schizophrenia, antipsychotics, and the metabolic syndrome: is there a silver lining?
authors.forename: Gary
authors.initials: G
authors.lastname: Remington
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003024:Clozapine / Q000009:adverse effects / Q000627:therapeutic use; D003430:Cross-Sectional Studies; D003695:Delivery of Health Care / Q000592:standards; D006801:Humans; D024821:Metabolic Syndrome / Q000139:chemically induced*; D009765:Obesity / Q000139:chemically induced; D012307:Risk Factors; D012559:Schizophrenia / Q000188:drug therapy*; D015430:Weight Gain / Q000187:drug effects
chemical_list: D014150:Antipsychotic Agents; D003024:Clozapine